Mitochondria, the vital energy power plants of the cells, can be damaged by the development of pathological concentrations of free oxygen radicals (ROS, reactive oxygen species = "oxidative stress"). This has partly massive effects in the organism up to burnout. The causes are extremely diverse, very often massive psychological stress, infections (e.g. infectious mononucleosis, influenza, corona), poor nutrition, bacterial overgrowth in the intestine, but also vaccinations can be found as a reason.
Possible consequences of a disturbed mitochondrial function can be, among others, concentration disorders, insomnia, constant tiredness & exhaustion ("fatigue"), burnout, increased feeling of hunger, pain and autoimmune diseases.
The oxidative stress and the damage to the mitochondria can be measured very well in the blood! In addition, we analyze the stress in the autonomic nervous system by means of heart rate variability measurement ("HRV"), a scientifically very well studied method in stress research.
In addition to high doses of targeted micronutrients, if necessary also in the form of infusions, IHHT ("Interval Hypoxia Hyperoxia Therapy" = "high altitude training") is the measure of choice for the targeted regeneration of mitochondria.
During IHHT, oxygen-poor, normal and oxygen-rich air is breathed in at intervals via a breathing mask. Each session lasts about 50 minutes. A minimum of 2 to 3 sessions per week and initially at least 10 sessions are required for good treatment success. Controlled hypoxia causes old mitochondria to be broken down and new ones to be built up. This is equivalent to altitude training. The IHHT technique is based on complex cellular mechanisms. The discovery of these processes was awarded the Nobel Prize in Medicine in 2019.
IHHT can be used, among other things, for acquired mitochondrial disorders, cardiovascular diseases, neurodegenerative diseases, obesity, pain, sleep disorders, constant fatigue and chronic exhaustion, especially also after viral infections (e.g. infectious mononucleosis, COVID-19).